Equibles does not estimate personal net worth.
Get an email with a short summary when Sionna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SION alertsThe proxy statement of Sionna Therapeutics, Inc. reports total compensation of $1,283,240 for Charlotte McKee in fiscal 2024, including a base salary of $449,946. Disclosed compensation is on record for 2 fiscal years. Charlotte McKee has spoken on 1 earnings call and 2 other investor events across 1 company, most recently for Sionna Therapeutics, Inc. on September 14, 2026. Sionna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sionna Therapeutics, Inc. includes Michael Cloonan (CEO), Elena Ridloff (CFO), H. Edward Fleming (Board Member) and 3 others.
“I have spent many years committed to developing medicines to help improve the lives of people with CF, and I am deeply and personally disappointed in today's announcement.”
“I have spent many years committed to developing medicines to help improve the lives of people with CF, and I am deeply and personally disappointed in today's announcement.”
“Yeah, so the next step, again, if we were to move this forward, would be dose-ranging, and, you know, we would, as Mike said, you know, we'd be looking at the appropriate dose range.”
Proxy statement
Start not stated–present
Last confirmed April 27, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Sionna Therapeutics, Inc. (SION) | Chief Medical Officer | $449,946 | $1,283,240 |
| 2023 | Sionna Therapeutics, Inc. (SION) | Chief Medical Officer | $432,640 | $623,002 |
